Results 231 to 240 of about 769,922 (292)
Surgical Versus Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis: 1-Year Clinical Outcomes in Patients Aged 65 Years and Older. [PDF]
Hemelrijk KI +32 more
europepmc +1 more source
Regenerative perfusion bioreactor for biologics production with lower COGs
Abstract Perfusion bioreactor systems enable intensified bioprocessing with high cell densities and volumetric productivities in monoclonal antibody (mAb) manufacturing. However, their widespread adoption remains constrained by the high consumption of chemically defined cell culture media.
Eric Wynne +5 more
wiley +1 more source
New Horizons in Transcatheter Aortic Valve Replacement: Expectations and Preparations. [PDF]
Nawaz H, Dahou A, Ahmad T.
europepmc +1 more source
ABSTRACT Percutaneous transaxillary access is an established alternative to transfemoral large‐bore arterial access for transcatheter structural heart interventions and mechanical circulatory support (MCS). Although useful for overcoming hostile iliofemoral anatomy and providing prolonged support and patient mobilization in case of MCS, the axillary ...
Gioel Gabrio Secco +9 more
wiley +1 more source
Impact of Concomitant Mitral Regurgitation in Moderate Aortic Stenosis: Assessment of Remodeling and Clinical Outcomes. [PDF]
Gabr EM +10 more
europepmc +1 more source
ABSTRACT Background Preprocedural planning with multislice computed tomography (MSCT) is an essential prerequisite for successful transcatheter aortic valve replacement (TAVR). However, preprocedural planning is time‐consuming and may contain clinically meaningful interobserver variability.
Mark M. P. van den Dorpel +11 more
wiley +1 more source
Early outcomes following multivalve heart operation in octogenarians. [PDF]
Abdelrehim AA +5 more
europepmc +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
ABSTRACT Background Vascular access site complications (VASCs) remain an important source of morbidity following percutaneous interventions. Although the sheath‐to‐femoral artery ratio is a recognized risk factor in transcatheter aortic valve implantation (TAVI), its role across a broader range of femoral procedures is less well defined.
Eduardo Ismael Arteaga Chan +2 more
wiley +1 more source

